en
Scientific article
English

Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics

Published inAlzheimer's & dementia, vol. 11, no. 10, p. 1191-1201
Publication date2015
Abstract

Proposed diagnostic criteria (international working group and National Institute on Aging and Alzheimer's Association) for Alzheimer's disease (AD) include markers of amyloidosis (abnormal cerebrospinal fluid [CSF] amyloid beta [Aβ]42) and neurodegeneration (hippocampal atrophy, temporo-parietal hypometabolism on [18F]-fluorodeoxyglucose-positron emission tomography (FDG-PET), and abnormal CSF tau). We aim to compare the accuracy of these biomarkers, individually and in combination, in predicting AD among mild cognitive impairment (MCI) patients.

Citation (ISO format)
PRESTIA, Annapaola et al. Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics. In: Alzheimer’s & dementia, 2015, vol. 11, n° 10, p. 1191–1201. doi: 10.1016/j.jalz.2014.12.001
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1552-5260
455views
0downloads

Technical informations

Creation08/25/2015 3:50:00 PM
First validation08/25/2015 3:50:00 PM
Update time03/14/2023 11:41:07 PM
Status update03/14/2023 11:41:06 PM
Last indexation01/16/2024 7:07:28 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack